S&P 500   5,251.84 (+0.06%)
DOW   39,728.06 (-0.08%)
QQQ   444.33 (-0.11%)
AAPL   171.12 (-1.26%)
MSFT   420.48 (-0.23%)
META   489.93 (-0.80%)
GOOGL   150.72 (-0.10%)
AMZN   180.92 (+0.61%)
TSLA   176.80 (-1.68%)
NVDA   902.50 (+0.00%)
NIO   4.62 (-1.07%)
AMD   182.17 (+1.44%)
BABA   72.39 (+1.12%)
T   17.54 (-0.06%)
F   13.16 (+0.77%)
MU   117.87 (-1.07%)
CGC   9.30 (-2.62%)
GE   176.51 (-2.00%)
DIS   122.99 (+1.66%)
AMC   3.82 (-11.98%)
PFE   27.82 (+0.14%)
PYPL   66.68 (+0.17%)
XOM   115.21 (+0.21%)
S&P 500   5,251.84 (+0.06%)
DOW   39,728.06 (-0.08%)
QQQ   444.33 (-0.11%)
AAPL   171.12 (-1.26%)
MSFT   420.48 (-0.23%)
META   489.93 (-0.80%)
GOOGL   150.72 (-0.10%)
AMZN   180.92 (+0.61%)
TSLA   176.80 (-1.68%)
NVDA   902.50 (+0.00%)
NIO   4.62 (-1.07%)
AMD   182.17 (+1.44%)
BABA   72.39 (+1.12%)
T   17.54 (-0.06%)
F   13.16 (+0.77%)
MU   117.87 (-1.07%)
CGC   9.30 (-2.62%)
GE   176.51 (-2.00%)
DIS   122.99 (+1.66%)
AMC   3.82 (-11.98%)
PFE   27.82 (+0.14%)
PYPL   66.68 (+0.17%)
XOM   115.21 (+0.21%)
S&P 500   5,251.84 (+0.06%)
DOW   39,728.06 (-0.08%)
QQQ   444.33 (-0.11%)
AAPL   171.12 (-1.26%)
MSFT   420.48 (-0.23%)
META   489.93 (-0.80%)
GOOGL   150.72 (-0.10%)
AMZN   180.92 (+0.61%)
TSLA   176.80 (-1.68%)
NVDA   902.50 (+0.00%)
NIO   4.62 (-1.07%)
AMD   182.17 (+1.44%)
BABA   72.39 (+1.12%)
T   17.54 (-0.06%)
F   13.16 (+0.77%)
MU   117.87 (-1.07%)
CGC   9.30 (-2.62%)
GE   176.51 (-2.00%)
DIS   122.99 (+1.66%)
AMC   3.82 (-11.98%)
PFE   27.82 (+0.14%)
PYPL   66.68 (+0.17%)
XOM   115.21 (+0.21%)
S&P 500   5,251.84 (+0.06%)
DOW   39,728.06 (-0.08%)
QQQ   444.33 (-0.11%)
AAPL   171.12 (-1.26%)
MSFT   420.48 (-0.23%)
META   489.93 (-0.80%)
GOOGL   150.72 (-0.10%)
AMZN   180.92 (+0.61%)
TSLA   176.80 (-1.68%)
NVDA   902.50 (+0.00%)
NIO   4.62 (-1.07%)
AMD   182.17 (+1.44%)
BABA   72.39 (+1.12%)
T   17.54 (-0.06%)
F   13.16 (+0.77%)
MU   117.87 (-1.07%)
CGC   9.30 (-2.62%)
GE   176.51 (-2.00%)
DIS   122.99 (+1.66%)
AMC   3.82 (-11.98%)
PFE   27.82 (+0.14%)
PYPL   66.68 (+0.17%)
XOM   115.21 (+0.21%)
CVE:ADK

DIAGNOS (ADK) Stock Price, News & Analysis

C$0.23
-0.01 (-2.13%)
(As of 09:30 AM ET)
Today's Range
C$0.23
C$0.23
50-Day Range
C$0.24
C$0.38
52-Week Range
C$0.23
C$0.59
Volume
11,900 shs
Average Volume
80,051 shs
Market Capitalization
C$17.43 million
P/E Ratio
N/A
Dividend Yield
0.29%
Price Target
C$1.50
ADK stock logo

About DIAGNOS Stock (CVE:ADK)

DIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. DIAGNOS Inc. was founded in 1998 and is headquartered in Brossard, Canada.

ADK Stock Price History

ADK Stock News Headlines

Got $1,000? 2 Stocks to Buy Now While They’re on Sale
DIAGNOS recognized as a Top TSX Venture Exchange Company
Buy Friday, Sell Monday, No Exceptions
Every week traders grind it out Monday through Friday… But neglect trading Friday to Monday… Or… “over the weekend” As one professional trader explains, trading over the weekend is one of the most forgiving strategies you can use today. It allows him to sidestep a lot of the midweek volatility. Yet, gives him the opportunity to target some of the markets biggest stock moves. Just recently, he posted a trade on Nordstrom… The trade was published at 3pm on a Friday afternoon and by Monday morning the trade more than doubled.
Closing Bell: Diagnos Inc flat on Thursday (ADK)
DIAGNOS Appoints New Chief Operating Officer
DIAGNOS Inc. (ADK.V)
Trending Stocks Sent To You In Real Time
Sign up today and get instant access to our next stock alert! You do not want to miss out on this next pick! Our stock picks have been known to soar!
Closing Bell: Diagnos Inc flat on Friday (ADK)
Diagnos Laboratorium Utama PT Tbk (DGNS)
Diagnos, Appulse, Bedford at 52-Week Highs
Closing Bell: Diagnos Inc down on Friday (ADK)
Echelon Wealth Partners Believes Diagnos (ADK) Won’t Stop Here
TMX, Arrow, CPKC at 52-Week Highs on News
Closing Bell: Diagnos Inc up on Wednesday (ADK)
Closing Bell: Diagnos Inc up on Monday (ADK)
Closing Bell: Diagnos Inc up on Thursday (ADK)
Closing Bell: Diagnos Inc up on Tuesday (ADK)
See More Headlines
Receive ADK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DIAGNOS and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/28/2024
Today
3/28/2024
Next Earnings (Estimated)
7/11/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Health Information Services
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
C$1.50
High Stock Price Target
C$1.50
Low Stock Price Target
C$1.50
Potential Upside/Downside
+552.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
C$-3,040,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$577,486.00
Cash Flow
C$0.00 per share
Book Value
C($0.04) per share

Miscellaneous

Free Float
N/A
Market Cap
C$17.43 million
Optionable
Not Optionable
Beta
-0.33
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

  • Mr. Andre Larente
    CEO, President & Executive Chairman
  • Mr. Marc-André Massue
    VP of Finance, CFO & Secretary
  • Mr. Yves-Stéphane Couture
    Chief Operating Officer
  • Mr. Martin Beland
    Director of Marketing

ADK Stock Analysis - Frequently Asked Questions

Should I buy or sell DIAGNOS stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for DIAGNOS in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ADK shares.
View ADK analyst ratings
or view top-rated stocks.

What is DIAGNOS's stock price target for 2024?

1 equities research analysts have issued 1-year target prices for DIAGNOS's stock. Their ADK share price targets range from C$1.50 to C$1.50. On average, they predict the company's share price to reach C$1.50 in the next twelve months. This suggests a possible upside of 552.2% from the stock's current price.
View analysts price targets for ADK
or view top-rated stocks among Wall Street analysts.

How have ADK shares performed in 2024?

DIAGNOS's stock was trading at C$0.41 at the start of the year. Since then, ADK stock has decreased by 43.2% and is now trading at C$0.23.
View the best growth stocks for 2024 here
.

When is DIAGNOS's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, July 11th 2024.
View our ADK earnings forecast
.

How were DIAGNOS's earnings last quarter?

DIAGNOS Inc. (CVE:ADK) released its earnings results on Wednesday, February, 28th. The company reported ($0.01) earnings per share for the quarter, hitting the consensus estimate of ($0.01). The company earned $0.05 million during the quarter, compared to the consensus estimate of $0.10 million.

What other stocks do shareholders of DIAGNOS own?

Based on aggregate information from My MarketBeat watchlists, some companies that other DIAGNOS investors own include Marijuana Company of America (MCOA), Maxar Technologies (MAXR) and Main Street Capital (MAIN).

How do I buy shares of DIAGNOS?

Shares of ADK stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:ADK) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners